Education
About Us
Working with TipRanks
Follow Us
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 1.90B | $ 1.24B | $ 933.01M | $ 701.89M | $ 540.10M |
| Gross Profit | $ 1.58B | $ 1.09B | $ 793.02M | $ 604.84M | $ 476.72M |
| Operating Income | $ 218.08M | $ -267.82M | $ -536.20M | $ -449.71M | $ -564.16M |
| EBITDA | $ 316.89M | $ -439.20M | $ -582.12M | $ -306.08M | $ -453.38M |
| Net Income | $ 235.24M | $ -535.98M | $ -703.49M | $ -418.78M | $ -554.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.35B | $ 1.68B | $ 1.99B | $ 2.12B | $ 1.94B |
| Total Assets | $ 3.96B | $ 3.26B | $ 3.13B | $ 3.15B | $ 2.98B |
| Total Debt | $ 1.33B | $ 1.40B | $ 1.62B | $ 1.14B | $ 1.07B |
| Net Debt | $ 226.59M | $ 968.38M | $ 650.58M | $ -977.48M | $ -429.79M |
| Total Liabilities | $ 2.44B | $ 2.41B | $ 2.74B | $ 2.22B | $ 2.22B |
| Stockholders' Equity | $ 1.53B | $ 859.34M | $ 384.95M | $ 928.01M | $ 761.76M |
| Cash Flow | |||||
| Free Cash Flow | $ -342.74M | $ -588.34M | $ -356.17M | $ -481.66M | $ 25.26M |
| Operating Cash Flow | $ -205.79M | $ -500.99M | $ -325.35M | $ -443.17M | $ 107.47M |
| Investing Cash Flow | $ 755.56M | $ -165.80M | $ -1.05B | $ 495.41M | $ -121.72M |
| Financing Cash Flow | $ 124.81M | $ 125.00M | $ 232.51M | $ 561.57M | $ 682.32M |